{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,13]],"date-time":"2025-12-13T23:07:32Z","timestamp":1765667252976,"version":"3.37.3"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2019,2,9]],"date-time":"2019-02-09T00:00:00Z","timestamp":1549670400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,2,9]],"date-time":"2019-02-09T00:00:00Z","timestamp":1549670400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"name":"1.3.5 project for disciplines of excellence, West China Hospital, Sichuan University","award":["No. ZY2016102"],"award-info":[{"award-number":["No. ZY2016102"]}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["No. 81501003"],"award-info":[{"award-number":["No. 81501003"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neurol"],"published-print":{"date-parts":[[2020,6]]},"DOI":"10.1007\/s00415-019-09198-z","type":"journal-article","created":{"date-parts":[[2019,2,9]],"date-time":"2019-02-09T07:05:27Z","timestamp":1549695927000},"page":"1577-1584","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Effectiveness and feasibility of cilostazol in patients with aneurysmal subarachnoid hemorrhage: a systematic review and meta-analysis"],"prefix":"10.1007","volume":"267","author":[{"given":"Tikun","family":"Shan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tiejun","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Weiqiang","family":"Qian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lu","family":"Ma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hao","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chao","family":"You","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaoqi","family":"Xie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,2,9]]},"reference":[{"key":"9198_CR1","doi-asserted-by":"publisher","first-page":"1711","DOI":"10.1161\/STR.0b013e3182587839","volume":"43","author":"ES Connolly","year":"2012","unstructured":"Connolly ES, Rabinstein AA, Carhuapoma JR, Derdeyn CP, Dion J, Higashida RT, Hoh BL, Kirkness CJ, Naidech AM, Ogilvy CS, Patel AB, Thompson BG, Vespa P, Council AHAS, Int CCR, Nursing CC, Anesthes CCS, Cardiology CC (2012) Guidelines for the management of aneurysmal subarachnoid hemorrhage a guideline for healthcare professionals from the American Heart Association\/American Stroke Association. Stroke 43:1711\u20131737. \nhttps:\/\/doi.org\/10.1161\/STR.0b013e3182587839","journal-title":"Stroke"},{"key":"9198_CR2","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1161\/STROKEAHA.110.597005","volume":"42","author":"RW Crowley","year":"2011","unstructured":"Crowley RW, Medel R, Dumont AS, Ilodigwe D, Kassell NF, Mayer SA, Ruefenacht D, Schmiedek P, Weidauer S, Pasqualin A, Macdonald RL (2011) Angiographic vasospasm is strongly correlated with cerebral infarction after subarachnoid hemorrhage. Stroke 42:919\u2013923. \nhttps:\/\/doi.org\/10.1161\/STROKEAHA.110.597005","journal-title":"Stroke"},{"key":"9198_CR3","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1007\/s00234-009-0575-y","volume":"51","author":"JW Dankbaar","year":"2009","unstructured":"Dankbaar JW, Rijsdijk M, van der Schaaf IC, Velthuis BK, Wermer MJH, Rinkel GJE (2009) Relationship between vasospasm, cerebral perfusion, and delayed cerebral ischemia after aneurysmal subarachnoid hemorrhage. Neuroradiology 51:813\u2013819. \nhttps:\/\/doi.org\/10.1007\/s00234-009-0575-y","journal-title":"Neuroradiology"},{"key":"9198_CR4","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD000277.pub3","author":"S Dorhout Mees","year":"2007","unstructured":"Dorhout Mees S, Rinkel GJE, Feigin VL, Algra A, van den Bergh WM, Vermeulen M, van Gijn J (2007) Calcium antagonists for aneurysmal subarachnoid haemorrhage. Cochrane Database Syst Rev. \nhttps:\/\/doi.org\/10.1002\/14651858.CD000277.pub3","journal-title":"Cochrane Database Syst Rev"},{"key":"9198_CR5","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1227\/01.NEU.0000255396.23280.31","volume":"60","author":"S Ferguson","year":"2007","unstructured":"Ferguson S, Macdonald RL (2007) Predictors of cerebral infarction in patients with aneurysmal subarachnoid hemorrhage. Neurosurgery 60:658\u2013667. \nhttps:\/\/doi.org\/10.1227\/01.NEU.0000255396.23280.31\n\n(discussion 667)","journal-title":"Neurosurgery"},{"key":"9198_CR6","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1016\/S1474-4422(08)70094-2","volume":"7","author":"YI Huang","year":"2008","unstructured":"Huang YI, Cheng Y, Wu J, Li YS, Xu E, Hong Z, Li ZY, Zhang WW, Ding MP, Gao XG, Fan DS, Zeng JS, Wong KS, Lu CZ, Xiao J, Yao C, Investigators CC (2008) Cilostazol as an alternative to aspirin after ischaemic stroke: a randomised, double-blind, pilot study. Lancet Neurol 7:494\u2013499. \nhttps:\/\/doi.org\/10.1016\/S1474-4422(08)70094-2","journal-title":"Lancet Neurol"},{"key":"9198_CR7","doi-asserted-by":"publisher","first-page":"2289","DOI":"10.2174\/1381612033453910","volume":"9","author":"K Junichi","year":"2003","unstructured":"Junichi K, Yongge L, Bing S, Yasmin S, Masuhiro Y, Frank C (2003) Cilostazol as a unique antithrombotic agent. Curr Pharm Des 9:2289\u20132302. \nhttps:\/\/doi.org\/10.2174\/1381612033453910","journal-title":"Curr Pharm Des"},{"key":"9198_CR8","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1007\/978-3-319-04981-6_25","volume":"120","author":"H Kimura","year":"2015","unstructured":"Kimura H, Okamura Y, Chiba Y, Shigeru M, Ishii T, Hori T, Shiomi R, Yamamoto Y, Fujimoto Y, Maeyama M, Kohmura E (2015) Cilostazol administration with combination enteral and parenteral nutrition therapy remarkably improves outcome after subarachnoid hemorrhage. Acta Neurochir Suppl 120:147\u2013152. \nhttps:\/\/doi.org\/10.1007\/978-3-319-04981-6_25","journal-title":"Acta Neurochir Suppl"},{"key":"9198_CR9","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1038\/nrneurol.2013.246","volume":"10","author":"RL Macdonald","year":"2014","unstructured":"Macdonald RL (2014) Delayed neurological deterioration after subarachnoid haemorrhage. Nat Rev Neurol 10:44\u201358. \nhttps:\/\/doi.org\/10.1038\/nrneurol.2013.246","journal-title":"Nat Rev Neurol"},{"key":"9198_CR10","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1159\/000445509","volume":"42","author":"N Matsuda","year":"2016","unstructured":"Matsuda N, Naraoka M, Ohkuma H, Shimamura N, Ito K, Asano K, Hasegawa S, Takemura A (2016) Effect of cilostazol on cerebral vasospasm and outcome in patients with aneurysmal subarachnoid hemorrhage: a randomized, double-blind, placebo-controlled trial. Cerebrovasc Dis 42:97\u2013105. \nhttps:\/\/doi.org\/10.1159\/000445509","journal-title":"Cerebrovasc Dis"},{"key":"9198_CR11","first-page":"393","volume":"41","author":"T Murahashi","year":"2013","unstructured":"Murahashi T, Kamiyama K, Hara K, Ozaki M, Mikamoto M, Nakagaki Y, Nakagaki Y, Nakamura H (2013) The efficiency of cilostazol for cerebral vasospasm following subarachnoid hemorrhage. No Shinkei Geka 41:393\u2013400","journal-title":"No Shinkei Geka"},{"key":"9198_CR12","doi-asserted-by":"publisher","first-page":"319","DOI":"10.3171\/2016.5.JNS152907","volume":"127","author":"Y Nakatsuka","year":"2016","unstructured":"Nakatsuka Y, Kawakita F, Yasuda R, Umeda Y, Toma N, Sakaida H, Suzuki H (2016) Preventive effects of cilostazol against the development of shunt-dependent hydrocephalus after subarachnoid hemorrhage. J Neurosurg 127:319\u2013326. \nhttps:\/\/doi.org\/10.3171\/2016.5.JNS152907","journal-title":"J Neurosurg"},{"key":"9198_CR13","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1016\/j.jns.2013.10.027","volume":"336","author":"PP Niu","year":"2014","unstructured":"Niu PP, Yang G, Xing YQ, Guo ZN, Yang Y (2014) Effect of cilostazol in patients with aneurysmal subarachnoid hemorrhage: a systematic review and meta-analysis. J Neurol Sci 336:146\u2013151. \nhttps:\/\/doi.org\/10.1016\/j.jns.2013.10.027","journal-title":"J Neurol Sci"},{"key":"9198_CR14","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1016\/j.jns.2013.10.027","volume":"10","author":"GJ Rinkel","year":"2011","unstructured":"Rinkel GJ, Algra A (2011) Long-term outcomes of patients with aneurysmal subarachnoid haemorrhage. Lancet Neurol 10:349\u2013356. \nhttps:\/\/doi.org\/10.1016\/j.jns.2013.10.027","journal-title":"Lancet Neurol"},{"key":"9198_CR15","doi-asserted-by":"publisher","first-page":"2979","DOI":"10.1016\/j.jstrokecerebrovasdis.2018.06.027","volume":"27","author":"H Saber","year":"2018","unstructured":"Saber H, Desai A, Palla M, Mohamed W, Seraji-Bozorgzad N, Ibrahim M (2018) Efficacy of cilostazol in prevention of delayed cerebral ischemia after aneurysmal subarachnoid hemorrhage: a meta-analysis. J Stroke Cerebrovasc Dis 27:2979\u20132985. \nhttps:\/\/doi.org\/10.1016\/j.jstrokecerebrovasdis.2018.06.027","journal-title":"J Stroke Cerebrovasc Dis"},{"key":"9198_CR16","doi-asserted-by":"publisher","first-page":"121","DOI":"10.3171\/2012.9.JNS12492","volume":"118","author":"N Senorita","year":"2013","unstructured":"Senorita N, Kinouchi H, Kanemaru K, Ohashi Y, Fukamachi A, Yagi S, Shimizu T, Furuya K, Uchida M, Takeuchi N, Nakano S, Koizumi H, Kobayashi C, Fukasawa I, Takahashi T, Kuroda K, Nishiyama Y, Yoshioka H, Horikoshi T (2013) Effects of cilostazol on cerebral vasospasm after aneurysmal subarachnoid hemorrhage: a multicenter prospective, randomized, open-label blinded end point trial. J Neurosurg 118:121\u2013130. \nhttps:\/\/doi.org\/10.3171\/2012.9.JNS12492","journal-title":"J Neurosurg"},{"key":"9198_CR17","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1159\/000327040","volume":"32","author":"S Suzuki","year":"2011","unstructured":"Suzuki S, Sayama T, Nakamura T, Nishimura H, Ohta M, Inoue T, Mannoji H, Takeshita I (2011) Cilostazol improves outcome after subarachnoid hemorrhage: a preliminary report. Cerebrovasc Dis 32:89\u201393. \nhttps:\/\/doi.org\/10.1159\/000327040","journal-title":"Cerebrovasc Dis"},{"key":"9198_CR18","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1177\/0271678X15621499","volume":"37","author":"T Takagi","year":"2017","unstructured":"Takagi T, Imai T, Mishiro K, Ishisaka M, Tsujimoto M, Ito H, Nagashima K, Matsukawa H, Tsuruma K, Shimazawa M, Yoshimura S, Kozawa O, Iwama T, Hara H (2017) Cilostazol ameliorates collagenase-induced cerebral hemorrhage by protecting the blood-brain barrier. J Cereb Blood Flow Metab 37:123\u2013139. \nhttps:\/\/doi.org\/10.1177\/0271678X15621499","journal-title":"J Cereb Blood Flow Metab"},{"key":"9198_CR19","doi-asserted-by":"publisher","first-page":"930","DOI":"10.1016\/j.jstrokecerebrovasdis.2014.12.002","volume":"24","author":"L Tan","year":"2015","unstructured":"Tan L, Margaret B, Zhang JH, Hu R, Yin Y, Cao L, Feng H, Zhang Y (2015) Efficacy and safety of cilostazol therapy in ischemic stroke: a meta-analysis. J Stroke Cerebrovasc Dis 24:930\u2013938. \nhttps:\/\/doi.org\/10.1016\/j.jstrokecerebrovasdis.2014.12.002","journal-title":"J Stroke Cerebrovasc Dis"},{"key":"9198_CR20","doi-asserted-by":"publisher","first-page":"2391","DOI":"10.1161\/STROKEAHA.110.589275","volume":"41","author":"MDI Vergouwen","year":"2010","unstructured":"Vergouwen MDI, Vermeulen M, van Gijn J, Rinkel GJE, Wijdicks EF, Muizelaar JP, Mendelow AD, Juvela S, Yonas H, Terbrugge KG, Macdonald RL, Diringer MN, Broderick JP, Dreier JP, Roos YBWEM (2010) Definition of delayed cerebral ischemia after aneurysmal subarachnoid hemorrhage as an outcome event in clinical trials and observational studies proposal of a multidisciplinary research group. Stroke 41:2391\u20132395. \nhttps:\/\/doi.org\/10.1161\/STROKEAHA.110.589275","journal-title":"Stroke"},{"key":"9198_CR21","doi-asserted-by":"publisher","first-page":"235","DOI":"10.2176\/nmc.49.235","volume":"49","author":"T Yoshimoto","year":"2009","unstructured":"Yoshimoto T, Shirasaka T, Fujimoto S, Yoshidumi T, Yamauchi T, Tokuda K, Kaneko S, Kashiwaba T (2009) Cilostazol may prevent cerebral vasospasm following subarachnoid hemorrhage. Neurol Med Chir 49:235\u2013240. \nhttps:\/\/doi.org\/10.2176\/nmc.49.235","journal-title":"Neurol Med Chir"}],"container-title":["Journal of Neurology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00415-019-09198-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-019-09198-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-019-09198-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,6,13]],"date-time":"2020-06-13T10:06:43Z","timestamp":1592042803000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00415-019-09198-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,2,9]]},"references-count":21,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2020,6]]}},"alternative-id":["9198"],"URL":"https:\/\/doi.org\/10.1007\/s00415-019-09198-z","relation":{},"ISSN":["0340-5354","1432-1459"],"issn-type":[{"type":"print","value":"0340-5354"},{"type":"electronic","value":"1432-1459"}],"subject":[],"published":{"date-parts":[[2019,2,9]]},"assertion":[{"value":"4 December 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 January 2019","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 January 2019","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 February 2019","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"I would like to declare on behalf of my co-authors that the work described was original research that has not been published previously, and not under the consideration for publication elsewhere, in whole or in part. In addition, no conflict of interest exists in our study. This article is a meta-analysis with all analyses based on previous published studies, thus no ethical approval and patient consent are required.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}}]}}